Novartis Benefits From Lack of Generic Challenge

April 24 (Bloomberg) -- Bloomberg's Jonathan Ferro reports that Novartis AG saw first-quarter profit rise 7 percent as a competitor's generic version of the company’s second-best-selling medicine failed to reach the market. He speaks on Bloomberg Television's "On The Move."
Boehner Defends His House Leadership Role
13:25 - Mar. 02 -- Jon Allen discusses John Boehner defending his house leadership role. He speaks with Trish Reagan on "Street Smart." (Source: Bloomberg)
  • Why Citigroup CEO Mike Corbat's Job May Be on the Line
  • What's the Upside to Investing in Russia?
  • Amgen's Kyprolis Tops Rival Drug in Study